
Lawsuit challenges new Idaho law that restricts benefits for undocumented immigrants
An Idaho doctor and four residents are challenging a new state law that halts some of the few public benefits available to people living in the U.S. unlawfully, including a program that provides access to life-saving HIV and AIDS medication for low income patients.
The ACLU of Idaho filed the federal lawsuit Thursday night on behalf of Dr. Abby Davids and four people with HIV who are not named because they are immigrants without lawful permanent residency.
The complaint says the new law is vague, contradicts federal law and makes it impossible for health care providers to determine exactly what kind of immigration status is excluded and how to verify that status for patients. They want a judge to grant them class-action status, expanding any ruling to other impacted people.
Dozens of patients treated by one Boise-area clinic stand to lose access to HIV and AIDS medication under the law, according to the complaint, including several cared for by Davids.
"Withdrawing HIV treatment from her patients will not only have devastating consequences on their health, it raises the public health risk of increased HIV transmission," the ACLU wrote in the lawsuit. "When her patients are undetectable, they cannot transmit the virus. Without HIV treatment, however, they cannot maintain an undetectable viral level and therefore are able to transmit the virus to others."
The new Idaho law takes effect July 1, and appears to be the first limiting public health benefits since President Trump ordered federal agencies to enhance eligibility verification and ensure that public benefits aren't going to ineligible immigrants.
The law requires people to verify that they are legal U.S. residents to receive public benefits like communicable disease testing, vaccinations, prenatal and postnatal care for women, crisis counseling, some food assistance for children and even access to food banks or soup kitchens that rely on public funding.
Federal law generally prohibits immigrants in the U.S. illegally from receiving taxpayer-funded benefits like Medicare, Medicaid, Temporary Assistance for Needy Families and Social Security. But there are some exceptions for things like emergency medical care and other emergency or public health services.
Idaho's law still allows for emergency medical services. But in a June 18 letter to health care providers, Idaho Division of Public Health administrator Elke Shaw-Tulloch said HIV is a long-term condition and not an emergency — so people must verify their lawful presence in order to get benefits through the federal Ryan White HIV/AIDS Program.
The HIV patients challenging the new law include a married couple from Columbia with pending asylum applications, a man who was brought to the U.S. when he was just 4 years old and has Deferred Action for Childhood Arrivals status until next year, and a man from Mexico who has been living and working in Idaho since 2020.
One of the patients said she and her husband were diagnosed with HIV in 2019 and immediately started antiretroviral therapy, receiving the medications at no cost through the Ryan White HIV/AIDS Program. The medication has lowered the viral load in her body enough that it is now undetectable, she wrote in a court filing, ensuring that she won't transmit the virus to others.
"My medication protected my daughter while I was pregnant because it prevented me from transmitting HIV to her during pregnancy," she wrote.
The treatment allows her to be with her child, watching her grow, she said.
Davids has been trying for weeks to get clarity from the Idaho Department of Health and Welfare about exactly what kind of verification her patients will have to show, and exactly which kinds of immigration status are considered "lawful." But the state has yet to provide clear direction, according to the complaint.
"I am really scared about what this means for many of our patients. Their lives will now be in jeopardy," Davids wrote in a May 30 email to the Department of Health and Welfare.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
14 minutes ago
- Yahoo
NORTHEAST GEORGIA MEDICAL'S LEVEL I TRAUMA CENTER ENROLLS 170TH PATIENT FOR PRYTIME MEDICAL'S INTERNATIONAL STUDY
GAINESVILLE, Ga., June 27, 2025 /PRNewswire/ -- When patients arrive at Northeast Georgia Medical Center (NGMC) in Gainesville with traumatic injuries, they're not only receiving the most advanced, expert care – they're helping to improve health care for people around the world. NGMC recently enrolled the 170th patient in the Partial REBOA Outcomes Multicenter ProspecTive (PROMPT) study, which shares data to improve outcomes for those critically injured patients. A pREBOA-PRO™ catheter was used to control life-threatening bleeding in the 170th patient, who arrived at the hospital's Level I Trauma Center, following a blunt trauma injury. The intervention stabilized the patient, reduced the need for additional blood products and ultimately saved their life. The trauma team at NGMC Gainesville routinely performs partial aortic occlusion – restricting blood flow through the aorta, the largest artery in the body – using the pREBOA-PRO™ device. As part of the PROMPT study, the team shares data on the use of the device to help advance clinical care. "When someone experiences a traumatic injury, every second matters," said Michael Cormican, MD, trauma surgeon at NGMC Gainesville. "We are grateful for the opportunity to support research that can lead to better outcomes for trauma patients." The international PROMPT study, funded by the Department of Defense, aims to ultimately enroll 340 patients across nine selected centers. NGMC patients who meet the study criteria are automatically enrolled. To learn more about NGMC's trauma program, visit ABOUT NORTHEAST GEORGIA MEDICAL CENTER Since 1951, Northeast Georgia Medical Center (NGMC) has been on a mission of improving the health of our community in all we do. With hospitals located in Gainesville, Braselton, Winder and Dahlonega, the four NGMC campuses have a total of more than 750 beds and more than 1,200 medical staff members representing more than 60 specialties. NGMC is part of Northeast Georgia Health System, a non-profit that cares for more than one million people across more than 19 counties. Learn more at ABOUT PRYTIME MEDICAL, INC. The pREBOA-PRO™ device is a product of Prytime Medical Inc, a leading innovator and global provider of lifesaving endovascular occlusion products. Prytime was selected by the U.S. Army Medical Research and Development Command to receive nearly $6 million from the U.S. Department of Defense awarded through the Medical Technology Enterprise Consortium. ABOUT U.S. ARMY MEDICAL RESEARCH AND DEVELOPMENT COMMAND The U.S. Army Medical Research and Development Command is the Army's medical materiel developer, with responsibility for medical research, development, and acquisition. USAMRDC produces medical solutions for the battlefield with a focus on various areas of biomedical research, including military infectious diseases, combat casualty care, military operational medicine, medical chemical and biological defense. ABOUT MTEC The Medical Technology Enterprise Consortium is a 501(c)(3) biomedical technology consortium that is internationally-dispersed, collaborating with multiple government agencies under a 10-year renewable Other Transaction Agreement with the U.S. Army Medical Research and Development Command. The consortium focuses on the development of medical solutions that protect, treat, and optimize the health and performance of U.S. military personnel and civilians. To find out more about MTEC, visit Disclaimer: The views and conclusions contained herein are those of the authors and should not be interpreted as representing the official policies or endorsements, either expressed or implied, of U.S. Government. CONTACT: Courtney Randolph, Public Relations & MarketingNortheast Georgia Medical Center743 Spring Street NE, Gainesville, GA 30501770-219-3840 | View original content to download multimedia: SOURCE Prytime Medical


Forbes
16 minutes ago
- Forbes
National HIV Testing Day Commemorates 30th Anniversary
LOS ANGELES - APRIL 28: A motorhome converted into a mobile HIV screening lab by the AIDS ... More Healthcare Foundation (AHF) is parked on a busy street on its first day of operations on April 28, 2004 in Los Angeles, California. The test reports a client's HIV status in only 20 minutes with accuracy reportedly greater than 99 percent using a single drop of blood drawn from the finger. AHF gives same-day counseling and support to walk-in clients who test positive to HIV. Rapid testing solves the problem of large numbers of people not returning for their test results from older methods that take as long as two week to return results. California's multi-billion dollar pornography industry is currently in a voluntary 60-day moratorium following the recent HIV infection of two porn stars who had been in sexual contact with dozens of people in the adult entertainment industry. (Photo by) Since 1995, National HIV Testing Day has provided a platform to raise awareness and confront stereotypes about HIV in the United States. The theme for 2025's Testing Day is 'Level up your self-love: check your status.' What is HIV? HIV is the acronym for human immunodeficiency virus. The initial symptoms of HIV resemble many other illnesses: chills, fatigue, fever, swollen lymph nodes, etc. In fact, some people may not know that they are positive for HIV because they may not have developed noticeable health symptoms at all. According to stats published by around half the amount of polled young people, ages 13-24, did not know if they were positive for HIV. In the same poll, around 30% of adults, ages 25-34, reported that they also did not know their HIV health status. If a person has HIV but hasn't been diagnosed, that person can unknowingly transmit the virus to others. Many medical professionals recommend routine HIV tests, especially for patients who already undergo STI screenings. Routine HIV testing can help diagnose an infection as early as possible. This prompt detection can ensure that an HIV-positive person can receive medical treatments to prevent HIV from advancing into AIDS. A common misconception conflates HIV and AIDS, or acquired immunodeficiency syndrome. As HIV enters its advanced stages, it can result in worsening damage to a patient's immune system. However, early diagnosis and antiretroviral (ARV) treatment can prevent HIV from developing into the more dangerous condition of AIDS. There is no current cure for HIV; however, the CDC emphasizes that 'people with HIV who get on and stay on effective HIV treatment can live long, healthy lives and protect their partners.' HIV can only spread through bodily fluids like breast milk, blood, semen, rectal, and vaginal fluids. Unprotected sex is a common method of transmission for HIV. Men who have anal sex with other men have historically been identified as experiencing a higher risk of potentially coming into contact with HIV. However, a person's sexual orientation is not innately a risk factor. Any person who experiences anal fissures or vaginal dryness might experience bleeding or minor tearing during unprotected sex. These damaged tissues can increase the risk of transmitting HIV because bodily fluids may come into contact with your mucus membrane. While HIV is often transmitted through sexual contact, there are other ways that the virus can spread. Contaminated needles can expose people to HIV. Mothers with HIV may transmit the virus to their children through breastfeeding. What Are Prevention and Testing Options? You can lower your risk for HIV and other illnesses by taking the following actions: - Use condoms and dental dams - Use medical-grade, sterile needles - Never share needles with other people, and never inject yourself with a needle someone else has already used - Disposing of medical equipment safely to avoid accidental needle pricks - Getting routinely tested for HIV Condoms are an effective tool for preventing the transmission of HIV because condoms limit your exposure to bodily fluids. According to a study published in the Journal of Acquired Immune Deficiency Syndromes, condoms are between 70%-80% effective at preventing the spread of HIV. If you worry that you may be at risk, you might consider a preventative treatment like Pre-Exposure Prophylaxis, or PrEP. For over ten years, PrEP has helped prevent patients from developing HIV. If you are interested in testing options, consult with your doctor or your local health department. On National HIV Testing Day, many pharmacies (including participating Walgreens locations across America) offer free rapid HIV tests and other resources.


New York Times
29 minutes ago
- New York Times
With Flu Shot Vote, Kennedy's Vaccine Skepticism Comes Full Circle
A decade before he became President Trump's health secretary, the environmental lawyer Robert F. Kennedy Jr. appeared on a talk show hosted by Dr. Mehmet Oz to promote his latest book, 'Thimerosal: Let the Science Speak.' The book, published in 2014, explored an obscure mercury-based preservative, thimerosal, that was removed from most vaccines, but not flu vaccines, more than two decades ago. Dr. Oz noted that the Centers for Disease Control and Prevention had deemed the vaccines that still contained thimerosal 'safe and effective' and said they did 'not present a public health risk.' Mr. Kennedy did not buy it. 'We found 500 peer-reviewed studies,' he insisted. 'Virtually every one of them said that thimerosal is a potent neurotoxin that should not be in vaccines.' On Thursday, the new members of the C.D.C.'s Advisory Committee on Immunization Practices, hand-selected by Mr. Kennedy after he fired all 17 members of the previous panel, decided it would longer recommend annual flu shots that contain it. Thimerosal's appearance on the committee's agenda in the first place shocked public health leaders, who have long considered the matter settled. But it was not a surprise to people who have followed Mr. Kennedy closely. Thimerosal started Mr. Kennedy down a path of questioning vaccine safety, and Thursday's vote was the culmination of a long personal journey. It offers a window into how, as secretary, he is pursuing his own passions and installing old allies in positions of influence. Want all of The Times? Subscribe.